Nothing Special   »   [go: up one dir, main page]

IL112519A0 - 5-heteroarylindole derivatives - Google Patents

5-heteroarylindole derivatives

Info

Publication number
IL112519A0
IL112519A0 IL11251995A IL11251995A IL112519A0 IL 112519 A0 IL112519 A0 IL 112519A0 IL 11251995 A IL11251995 A IL 11251995A IL 11251995 A IL11251995 A IL 11251995A IL 112519 A0 IL112519 A0 IL 112519A0
Authority
IL
Israel
Prior art keywords
heteroarylindole
derivatives
heteroarylindole derivatives
Prior art date
Application number
IL11251995A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL112519A0 publication Critical patent/IL112519A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
IL11251995A 1994-02-10 1995-02-02 5-heteroarylindole derivatives IL112519A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19455394A 1994-02-10 1994-02-10

Publications (1)

Publication Number Publication Date
IL112519A0 true IL112519A0 (en) 1995-05-26

Family

ID=22718035

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11251995A IL112519A0 (en) 1994-02-10 1995-02-02 5-heteroarylindole derivatives

Country Status (12)

Country Link
US (1) US5688809A (no)
EP (1) EP0743942A1 (no)
JP (1) JP2829788B2 (no)
KR (1) KR970701182A (no)
CN (1) CN1067386C (no)
AU (1) AU685881B2 (no)
CA (1) CA2183084A1 (no)
FI (1) FI950568A (no)
IL (1) IL112519A0 (no)
NO (1) NO963331L (no)
NZ (1) NZ276172A (no)
WO (1) WO1995021836A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ502642A (en) * 1997-07-03 2002-06-28 Du Pont Pharm Co Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
US6365589B1 (en) 1998-07-02 2002-04-02 Bristol-Myers Squibb Pharma Company Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
UA82395C2 (en) * 2003-08-21 2008-04-10 Оси Фармасьютикалз, Инк. N-substituted benzimidazolyl c-kit inhibitors
US7442709B2 (en) * 2003-08-21 2008-10-28 Osi Pharmaceuticals, Inc. N3-substituted imidazopyridine c-Kit inhibitors
CN1839130A (zh) 2003-08-21 2006-09-27 Osi制药公司 N-取代的吡唑基-酰胺基-苯并咪唑基的c-kit抑制剂
JP2008521903A (ja) * 2004-12-01 2008-06-26 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド N置換されたベンズイミダゾリルC−kit阻害剤及びコンビナトリアルベンゾイミダゾールライブラリー
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
US9394285B2 (en) 2013-03-15 2016-07-19 Pfizer Inc. Indole and indazole compounds that activate AMPK
JP6800885B2 (ja) 2015-04-29 2020-12-16 ヤンセン ファーマシューティカ エヌ.ベー. イミダゾピラジン及びピラゾロピリミジン、並びにampa受容体調節物質としてのこれらの使用
US10611730B2 (en) 2015-04-29 2020-04-07 Janssen Pharmaceutica Nv Benzimidazolone and benzothiazolone compounds and their use as AMPA receptor modulators
SG11201708190UA (en) 2015-04-29 2017-11-29 Janssen Pharmaceutica Nv Azabenzimidazoles and their use as ampa receptor modulators
EP3288935B1 (en) 2015-04-29 2019-10-30 Janssen Pharmaceutica NV Indolone compounds and their use as ampa receptor modulators
KR101831553B1 (ko) 2017-01-23 2018-02-22 계명대학교 산학협력단 전이성 유방암의 유용한 신규 화합물 및 이의 의학적 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066654A (en) * 1990-10-22 1991-11-19 A. H. Robins Company, Incorporated 2-aryl-3-heterocyclicmethyl-3H-imidazo[4,5-b]pyridines as anxiolytics and anticonvulsants
GB9210400D0 (en) * 1992-05-15 1992-07-01 Merck Sharp & Dohme Therapeutic agents
TW251284B (no) * 1992-11-02 1995-07-11 Pfizer

Also Published As

Publication number Publication date
FI950568A (fi) 1995-08-11
CA2183084A1 (en) 1995-08-17
WO1995021836A1 (en) 1995-08-17
AU685881B2 (en) 1998-01-29
KR970701182A (ko) 1997-03-17
NZ276172A (en) 1998-02-26
US5688809A (en) 1997-11-18
EP0743942A1 (en) 1996-11-27
NO963331D0 (no) 1996-08-09
JP2829788B2 (ja) 1998-12-02
CN1142823A (zh) 1997-02-12
AU1033995A (en) 1995-08-29
JPH09501949A (ja) 1997-02-25
FI950568A0 (fi) 1995-02-09
NO963331L (no) 1996-10-09
CN1067386C (zh) 2001-06-20

Similar Documents

Publication Publication Date Title
ZA952413B (en) 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives
AP9700954A0 (en) 6-ohenylpyridyl-2-amine derivatives
GB9511077D0 (en) 17B-Substituted-6-azasteroid derivatives
AP9701156A0 (en) 6-phenylpyridyl-2-amine derivatives
IL125379A (en) 19-nor-pregnene derivatives
EP0708091A3 (en) Indoloylguanidine derivatives
ZA953356B (en) Benzocycloalkylazolethione derivatives
HUP9902993A3 (en) Alkylaminobenzothiazole and -benzoxazole derivatives
EP0747348A4 (en) AMINOALKYLCYCLOPROPAN DERIVATIVES
EP0692482A3 (en) 1-pyridyltetrazolinone derivatives
HUP9701835A3 (en) Vinyl-pirrolidinone-cephalosporin derivatives
GB2295614B (en) Novel 5-pyrrolyl-6-halogeno-2-pyridylmethylsulfinylbenzimidazole derivatives
IL112519A0 (en) 5-heteroarylindole derivatives
IL113604A0 (en) Novel dialkoxy-pyridinyl-benzimidazole derivatives
HU9503339D0 (en) Amino-cyclopentane derivative
IL125149A0 (en) Pyrazol-4-yl-hetaroyl derivatives
GB9511365D0 (en) Pyridazino-indole derivatives
HU9503582D0 (en) Thienopyridon derivatives
HU9701479D0 (en) N-benzylazolium derivatives
GB9604996D0 (en) Benzodiazonine derivatives
GB9603226D0 (en) Heterocyclyl-ergoline derivatives
GB9600063D0 (en) Guaridine derivatives
IL125974A0 (en) 2-thioxotetrahydropyrimidin-4-one derivatives
GB9702049D0 (en) Tetrahhydroisoquinoline derivatives
GB2291425B (en) 7-Diazo-beta-lactam derivatives